Ro24-4736 is a long-acting, selective platelet-activating factor (PAF) antagonist; it inhibits PAF-induced platelet aggregation in guinea pigs, dogs, and humans in a concentration-dependent manner; it dose-dependently inhibits PAF-induced bronchoconstriction (ID₅₀ = 0.006 mg/kg p.o.) and ex vivo platelet aggregation (ID₅₀ = 0.004 mg/kg p.o.) in guinea pigs; it attenuates inhaled antigen-induced airway hyper-reactivity in sensitized guinea pigs without affecting bronchoalveolar lavage leukocyte accumulation.